Literature DB >> 6378495

Group B streptococcus arthritis.

R Colebunders, E Cytryn, J P Thys.   

Abstract

Serious infections with group B streptococcus (streptococcus agalactiae) are rare in adults. A 81-year-old patient with cirrhosis who developed a septic arthritis due to this germ, is described. Only eleven cases of group B streptococcal arthritis have been previously reported.

Entities:  

Mesh：

Year:  1983        PMID： 6378495     DOI： 10.1007/bf02041567

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


  6 in total

1.  NEONATAL SEPSIS AND OTHER INFECTIONS DUE TO GROUP B BETA-HEMOLYTIC STREPTOCOCCI.

Authors:  T C EICKHOFF; J O KLEIN; A K DALY; D INGALL; M FINLAND
Journal:  N Engl J Med       Date:  1964-12-10       Impact factor: 91.245

2.  Double-Zone Beta-Hemolytic Streptococci: Their Cultural Characteristics, Serological Grouping, Occurrence and Pathogenic Significance.

Authors:  J H Brown
Journal:  J Bacteriol       Date:  1939-02       Impact factor: 3.490

3.  Serious infections in adults due to group B streptococci. Clinical and serotypic characterization.

Authors:  A S Bayer; A W Chow; B F Anthony; L B Guze
Journal:  Am J Med       Date:  1976-10       Impact factor: 4.965

4.  Antibiotic-killing kinetics of group B streptococci.

Authors:  V Schauf; A Deveikis; L Riff; A Serota
Journal:  J Pediatr       Date:  1976-08       Impact factor: 4.406

5.  Infectious arthritis.

Authors:  J T Sharp; M D Lidsky; J Duffy; M W Duncan
Journal:  Arch Intern Med       Date:  1979-10

6.  Serious group B beta-hemolytic streptococcal infections in adults: report of two cases and review of the literature.

Authors:  J M Nicklas
Journal:  Johns Hopkins Med J       Date:  1978-02
  6 in total
  1 in total

1.  Klebsiella pneumoniae septic arthritis in a cirrhotic patient with hepatocellular carcinoma.

Authors:  Chang Hwan Park; Young Eun Joo; Sung Kyu Choi; Jong Sun Rew; Sei Jong Kim
Journal:  J Korean Med Sci       Date:  2004-08       Impact factor: 2.153
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.